Advancing Oncology Research and Therapeutics
Transforming cancer care through innovative research, precision diagnostics and clinical trial support.
Versiti Clinical Trials is dedicated to accelerating the development of cutting-edge oncology therapies. With expertise spanning hematologic cancers, solid tumors, immuno-oncology and precision medicine, we provide a full suite of services designed to support your oncology research goals.
Cancer Immunotherapies
We specialize in the development and validation of immunotherapies, including CAR-T cell therapies, checkpoint inhibitors and vaccines, advancing the treatment of both hematologic and solid tumors.
Precision Oncology and Biomarker Development
Our expertise in biomarker discovery and validation empowers researchers to develop precision oncology treatments, optimizing therapy efficacy and patient outcomes based on genetic and molecular profiles.
Early-Phase Clinical Trials
Versiti Clinical Trials supports oncology clinical trials across all phases, with a focus on early-phase trials that explore novel therapies and treatment combinations. Our team ensures compliance, efficiency and scientific rigor in every study.
Our Approach to Oncology Research
Comprehensive Trial Support: From feasibility and protocol development to patient recruitment and data analysis, we offer end-to-end support for oncology clinical trials.
Regulatory Expertise: Our regulatory team ensures trials meet global standards, ensuring compliance with FDA, EMA and other relevant health authorities.
State-of-the-Art Laboratories: Equipped with advanced technologies, our labs offer precise testing and sample analysis for oncology research.